ArticleCancers2021

Her2 Expression in Circulating Tumor Cells Is Associated with Poor Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer.

Denis Maillet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.